These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Antigenic markers of the hemagglutinins of the influenza A and B viruses in the process of variability and the rapid diagnosis of influenza]. Rovnova ZI, Isaeva EI, Demidova SA, Ignat'eva TV, Poliakova TG. Vopr Virusol; 1986 Jul; 31(2):229-34. PubMed ID: 2425495 [No Abstract] [Full Text] [Related]
26. [The results of a study of the data obtained from patients vaccinated earlier with different influenza vaccines]. Ivanova VT, Slepushkin AN, Burtseva EI, Oskerko TA, Golubeva LI, Beliaev AL. Vopr Virusol; 1994 Jul; 39(2):66-8. PubMed ID: 8017055 [Abstract] [Full Text] [Related]
27. [Comparative characteristics of hemagglutinins of influenza A viruses with antigenic structure Hsw1N1 isolated from man and animals]. Dem'ianenko IV, Shilov AA, Chuvakova ZK, Chaĭka OV, Isaeva EI. Vopr Virusol; 1988 Jul; 33(2):157-62. PubMed ID: 2970717 [Abstract] [Full Text] [Related]
28. Antigenic and genetic characterization of the haemagglutinins of recent cocirculating strains of influenza B virus. Rota PA, Hemphill ML, Whistler T, Regnery HL, Kendal AP. J Gen Virol; 1992 Oct; 73 ( Pt 10)():2737-42. PubMed ID: 1402807 [Abstract] [Full Text] [Related]
29. [The antigenic and biological properties of influenza A (H1N1) viruses isolated in the USSR and the Czechoslovak Federal Republic in 1988-1989]. Ivanova VT, Iakhno MA, Soljariková L, Stumpa A, Varicková E, Slepushkin AN. Vopr Virusol; 1991 Oct; 36(5):378-80. PubMed ID: 1803768 [Abstract] [Full Text] [Related]
30. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine. Skowronski DM, Janjua NZ, Sabaiduc S, De Serres G, Winter AL, Gubbay JB, Dickinson JA, Fonseca K, Charest H, Bastien N, Li Y, Kwindt TL, Mahmud SM, Van Caeseele P, Krajden M, Petric M. J Infect Dis; 2014 Jul 01; 210(1):126-37. PubMed ID: 24446529 [Abstract] [Full Text] [Related]
31. [Isolation and characteristics of monoclonal antibodies to influenza virus types A and B]. Busse TL, Khristova ML, Sokolova MV, Kharitonenkov IG, Saranpa M. Vopr Virusol; 1988 Jul 01; 33(5):543-7. PubMed ID: 3064429 [Abstract] [Full Text] [Related]
34. Growth and immunogenicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs. Govorkova EA, Kodihalli S, Alymova IV, Fanget B, Webster RG. Dev Biol Stand; 1999 Sep 29; 98():39-51; discussion 73-4. PubMed ID: 10494958 [Abstract] [Full Text] [Related]
37. Expression of viral antigens after infection of human lymphocytes, monocytes, and macrophages with influenza virus. Roberts NJ, Horan PK. J Infect Dis; 1985 Feb 29; 151(2):308-13. PubMed ID: 3881540 [Abstract] [Full Text] [Related]
38. [Polymorphism of current human influenza A and B virus population]. Grinbaum EB, Litvinova OM, Bannikov AI, Konovalenko IB, Chernookaia NIu, Iukhnova LG, Kiselev OI. Vestn Ross Akad Med Nauk; 1994 Feb 29; (9):36-40. PubMed ID: 7532493 [Abstract] [Full Text] [Related]
39. The epidemiology of influenza in children. Arden NH. Pediatr Ann; 2000 Nov 29; 29(11):678-82. PubMed ID: 11098517 [No Abstract] [Full Text] [Related]